"Simmons Cancer Institute at SIU practices “the team approach” to cancer treatment. Our team – the surgeons, radiologists, oncologists, genetic counselors, therapists, nurses and medical staff – meet together to decide the best treatment plan when you or your family member receives a cancer diagnosis. When the patient leaves SCI after receiving a cancer diagnosis, it’s not with a list of appointments for other opinions about treatment. It’s with a treatment plan and the knowledge that their cancer care team is working for the best possible outcome."

During the past decade, Simmons Cooper Cancer Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 17 clinical trials were completed, i.e. on average, 170% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Simmons Cooper Cancer Institute" #1 sponsor was "Children's Oncology Group" with 13 trials, followed by "Southern Illinois University" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Simmons Cooper Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Children's Cancer and Leukaemia Group" with 1 trials as a collaborator, "Children's Oncology Group" with 1 trials as a collaborator and "EBMT Solid Tumors Working Party" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Simmons Cooper Cancer Institute" are "Sarcoma" (4 trials), "Central Nervous System Tumors" (3 trials), "Leukemia" (3 trials), "Brain Tumor" (2 trials) and "Brain Tumors" (2 trials). Many other conditions were trialed in "Simmons Cooper Cancer Institute" in a lesser frequency.

Most popular intervention types in "Simmons Cooper Cancer Institute" are "Drug" (26 trials), "Procedure" (8 trials), "Radiation" (8 trials), "Biological" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "etoposide" (6 trials), "radiation therapy" (6 trials), "vincristine sulfate" (5 trials), "conventional surgery" (4 trials) and "cyclophosphamide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Simmons Cooper Cancer Institute" are 30 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Simmons Cooper Cancer Institute". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Simmons Cooper Cancer Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Simmons Cooper Cancer Institute, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".